Ardelyx, Inc.
US ˙ NasdaqGM ˙ US0396971071

Introduction

This page provides a comprehensive analysis of the known insider trading history of Michael Raab. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Michael Raab has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ARDX / Ardelyx, Inc. President & CEO, Director 1,502,250
US:FOLD / Amicus Therapeutics, Inc. Director 115,857
US:TPST / Tempest Therapeutics, Inc. Director 6,635
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Michael Raab. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ARDX / Ardelyx, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ARDX / Ardelyx, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2022-08-31 ARDX RAAB MICHAEL 3,000 0.6188 3,000 0.6188 1,856 233 4.9500 12,994 700.11

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ARDX / Ardelyx, Inc. Insider Trades
Insider Sales ARDX / Ardelyx, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ARDX / Ardelyx, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-08-21 ARDX RAAB MICHAEL 45,687 5.9317 45,687 5.9317 271,002 4 6.0600 5,862 2.16
2025-05-20 ARDX RAAB MICHAEL 46,817 4.0814 46,817 4.0814 191,079
2025-05-02 ARDX RAAB MICHAEL 41,666 4.2521 41,666 4.2521 177,168
2025-02-20 ARDX RAAB MICHAEL 22,964 5.6229 22,964 5.6229 129,124
2025-01-07 ARDX RAAB MICHAEL 41,666 5.3115 41,666 5.3115 221,309
2024-11-20 ARDX RAAB MICHAEL 31,980 4.7945 31,980 4.7945 153,328
2024-08-20 ARDX RAAB MICHAEL 32,225 5.8603 32,225 5.8603 188,848
2024-06-13 ARDX RAAB MICHAEL 35,000 6.6498 35,000 6.6498 232,743
2024-05-21 ARDX RAAB MICHAEL 31,484 7.8110 31,484 7.8110 245,922
2024-02-20 ARDX RAAB MICHAEL 22,917 8.7463 22,917 8.7463 200,439
2023-11-20 ARDX RAAB MICHAEL 11,368 4.3622 11,368 4.3622 49,589
2023-08-21 ARDX RAAB MICHAEL 11,419 3.5518 11,419 3.5518 40,558
2023-05-23 ARDX RAAB MICHAEL 11,357 3.6532 11,357 3.6532 41,489
2023-02-21 ARDX RAAB MICHAEL 13,449 3.0010 13,449 3.0010 40,360
2022-11-22 ARDX RAAB MICHAEL 162 1.9400 162 1.9400 314
2022-11-22 ARDX RAAB MICHAEL 121 1.9419 121 1.9419 235
2022-11-22 ARDX RAAB MICHAEL 5,936 1.9493 5,936 1.9493 11,571
2022-08-22 ARDX RAAB MICHAEL 6,016 0.9837 6,016 0.9837 5,918
2022-08-22 ARDX RAAB MICHAEL 54 0.9801 54 0.9801 53
2022-08-22 ARDX RAAB MICHAEL 76 0.9802 76 0.9802 74
2022-06-06 ARDX RAAB MICHAEL 101,480 0.6509 101,480 0.6509 66,053
2022-06-06 ARDX RAAB MICHAEL 2,144 0.6357 2,144 0.6357 1,363
2022-05-20 ARDX RAAB MICHAEL 6,124 0.6714 6,124 0.6714 4,112
2022-02-22 ARDX RAAB MICHAEL 6,229 0.6700 6,229 0.6700 4,173
2021-11-22 ARDX RAAB MICHAEL 2,607 0.9919 2,607 0.9919 2,586
2021-08-20 ARDX RAAB MICHAEL 2,573 1.3200 2,573 1.3200 3,396
2021-05-20 ARDX RAAB MICHAEL 2,534 7.0878 2,534 7.0878 17,960
2021-02-22 ARDX RAAB MICHAEL 2,534 6.8825 2,534 6.8825 17,440
2020-09-15 ARDX RAAB MICHAEL 106,337 5.6075 106,337 5.6075 596,285
2019-06-04 ARDX RAAB MICHAEL 10,054 2.5414 10,054 2.5414 25,551
2019-01-02 ARDX RAAB MICHAEL 19,644 1.7012 19,644 1.7012 33,418
2018-11-13 ARDX RAAB MICHAEL 6,539 2.8400 6,539 2.8400 18,571

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ARDX / Ardelyx, Inc. Insider Trades
Insider Purchases FOLD / Amicus Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ARDX / Ardelyx, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

FOLD / Amicus Therapeutics, Inc. Insider Trades
Insider Sales FOLD / Amicus Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ARDX / Ardelyx, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2023-03-17 FOLD RAAB MICHAEL 4,408 11.3300 4,408 11.3300 49,943 237 9.9750 -5,972 -11.96

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

FOLD / Amicus Therapeutics, Inc. Insider Trades
Insider Purchases TPST / Tempest Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ARDX / Ardelyx, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TPST / Tempest Therapeutics, Inc. Insider Trades
Insider Sales TPST / Tempest Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ARDX / Ardelyx, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TPST / Tempest Therapeutics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Michael Raab as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-08-25 2025-08-21 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -45,687 1,502,250 -2.95 5.93 -271,002 8,910,896
2025-06-06 2025-06-05 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 20,414 115,857 21.39
2025-05-22 2025-05-20 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -46,817 1,547,937 -2.94 4.08 -191,079 6,317,750
2025-05-05 2025-05-02 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -41,666 1,594,754 -2.55 4.25 -177,168 6,781,053
2025-05-05 2025-05-02 4 ARDX ARDELYX, INC.
Common Stock
M - Exercise X 20,833 1,636,420 1.29 0.99 20,625 1,620,056
2025-04-08 2025-04-04 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -41,666 1,615,587 -2.51 4.59 -191,151 7,411,828
2025-04-08 2025-04-04 4 ARDX ARDELYX, INC.
Common Stock
M - Exercise X 20,833 1,657,253 1.27 0.99 20,625 1,640,680
2025-03-07 2025-03-07 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -41,668 1,635,138 -2.48 5.36 -223,199 8,758,780
2025-03-07 2025-03-07 4 ARDX ARDELYX, INC.
Common Stock
M - Exercise X 20,834 1,676,806 1.26 0.99 20,626 1,660,038
2025-02-27 2025-02-25 4 ARDX ARDELYX, INC.
Common Stock
A - Award 570,217 1,655,972 52.52
2025-02-21 2025-02-20 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -22,964 1,085,755 -2.07 5.62 -129,124 6,105,092
2025-01-31 2025-01-31 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -41,666 1,108,719 -3.62 5.36 -223,355 5,943,399
2025-01-31 2025-01-31 4 ARDX ARDELYX, INC.
Common Stock
M - Exercise X 20,833 1,150,385 1.84 0.99 20,625 1,138,881
2025-01-10 2025-01-07 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -41,666 1,129,552 -3.56 5.31 -221,309 5,999,615
2025-01-10 2025-01-07 4 ARDX ARDELYX, INC.
Common Stock
M - Exercise X 20,833 1,171,218 1.81 0.99 20,625 1,159,506
2024-12-12 2024-12-10 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -25,000 1,150,385 -2.13 5.26 -131,620 6,056,547
2024-12-12 2024-12-10 4 ARDX ARDELYX, INC.
Common Stock
M - Exercise X 25,000 1,175,385 2.17 0.99 24,750 1,163,631
2024-11-27 2024-11-25 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -25,000 1,150,385 -2.13 5.38 -134,482 6,188,266
2024-11-22 2024-11-20 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -31,980 1,175,385 -2.65 4.79 -153,328 5,635,383
2024-11-12 2024-11-11 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -2,743 1,207,365 -0.23 4.90 -13,441 5,916,088
2024-10-31 2024-10-28 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -25,000 1,210,108 -2.02 5.91 -147,740 7,151,254
2024-10-31 2024-10-28 4 ARDX ARDELYX, INC.
Common Stock
M - Exercise X 25,000 1,235,108 2.07 0.99 24,750 1,222,757
2024-10-15 2024-10-11 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -7,500 1,210,108 -0.62 6.01 -45,075 7,272,749
2024-09-27 2024-09-26 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -3,000 1,217,608 -0.25 6.07 -18,210 7,390,881
2024-09-13 2024-09-11 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -35,000 1,220,608 -2.79 5.61 -196,399 6,849,320
2024-09-13 2024-09-11 4 ARDX ARDELYX, INC.
Common Stock
M - Exercise X 35,000 1,255,608 2.87 0.99 34,650 1,243,052
2024-08-28 2024-08-27 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -7,500 1,219,509 -0.61 6.22 -46,635 7,582,907
2024-08-22 2024-08-20 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -32,225 1,227,009 -2.56 5.86 -188,848 7,190,641
2024-08-14 2024-08-12 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -1,229 1,259,234 -0.10 5.71 -7,018 7,190,226
2024-07-31 2024-07-29 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -30,000 1,260,463 -2.32 5.64 -169,314 7,113,801
2024-07-31 2024-07-29 4 ARDX ARDELYX, INC.
Common Stock
M - Exercise X 30,000 1,290,463 2.38 0.99 29,700 1,277,558
2024-07-17 2024-07-15 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -7,500 1,260,463 -0.59 5.97 -44,768 7,523,704
2024-06-28 2024-06-28 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -2,310 1,267,963 -0.18 6.59 -15,223 8,355,876
2024-06-17 2024-06-13 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -35,000 1,270,273 -2.68 6.65 -232,743 8,447,061
2024-06-17 2024-06-13 4 ARDX ARDELYX, INC.
Common Stock
M - Exercise 35,000 1,305,273 2.76 0.99 34,650 1,292,220
2024-06-07 2024-06-06 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 11,847 95,443 14.17
2024-05-31 2024-05-29 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -7,500 1,270,273 -0.59 6.72 -50,390 8,534,583
2024-05-23 2024-05-21 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -31,484 1,277,773 -2.40 7.81 -245,922 9,980,685
2024-05-15 2024-05-14 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -3,000 1,307,933 -0.23 7.99 -23,970 10,450,385
2024-05-01 2024-04-29 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -30,000 1,310,933 -2.24 6.40 -192,057 8,392,462
2024-05-01 2024-04-29 4 ARDX ARDELYX, INC.
Common Stock
M - Exercise X 30,000 1,340,933 2.29 0.99 29,700 1,327,524
2024-04-17 2024-04-15 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -7,500 1,310,933 -0.57 7.06 -52,924 9,250,599
2024-04-02 2024-04-01 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -1,518 1,318,433 -0.12 7.31 -11,097 9,637,745
2024-03-06 2024-03-05 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 15,000 83,596 21.87 2.80 42,000 234,069
2024-02-22 2024-02-20 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -22,917 1,319,951 -1.71 8.75 -200,439 11,544,687
2024-01-18 2024-01-16 4 ARDX ARDELYX, INC.
Common Stock
A - Award 475,000 1,342,868 54.73
2023-11-22 2023-11-20 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -11,368 867,868 -1.29 4.36 -49,589 3,785,814
2023-08-23 2023-08-21 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -11,419 876,236 -1.29 3.55 -40,558 3,112,215
2023-06-12 2023-06-08 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 8,584 68,596 14.30
2023-05-25 2023-05-23 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -11,357 887,655 -1.26 3.65 -41,489 3,242,781
2023-03-21 2023-03-17 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale -4,408 60,012 -6.84 11.33 -49,943 679,936
2023-03-21 2023-03-17 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 15,000 64,420 30.35 3.32 49,800 213,874
2023-02-24 2023-02-21 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -13,449 896,012 -1.48 3.00 -40,360 2,688,932
2023-01-06 2023-01-05 4 ARDX ARDELYX, INC.
Common Stock
A - Award 250,000 909,461 37.91
2022-11-23 2022-11-22 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -5,936 659,461 -0.89 1.95 -11,571 1,285,487
2022-11-23 2022-11-22 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -121 665,397 -0.02 1.94 -235 1,292,134
2022-11-23 2022-11-22 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -162 665,518 -0.02 1.94 -314 1,291,105
2022-09-01 2022-08-31 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 3,000 665,680 0.45 0.62 1,856 411,923
2022-08-24 2022-08-22 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -76 662,680 -0.01 0.98 -74 649,559
2022-08-24 2022-08-22 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -54 662,756 -0.01 0.98 -53 649,567
2022-08-24 2022-08-22 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -6,016 662,810 -0.90 0.98 -5,918 652,006
2022-06-10 2022-06-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 12,671 49,420 34.48
2022-06-08 2022-06-06 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -2,144 668,826 -0.32 0.64 -1,363 425,173
2022-06-08 2022-06-06 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -101,480 670,970 -13.14 0.65 -66,053 436,734
2022-05-23 2022-05-20 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -6,124 772,450 -0.79 0.67 -4,112 518,623
2022-05-04 2022-05-02 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
M - Exercise -15,000 0 -100.00
2022-05-04 2022-05-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -15,000 36,749 -28.99 6.99 -104,890 256,975
2022-05-04 2022-05-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 15,000 51,749 40.82 4.79 71,850 247,878
2022-02-25 2022-02-22 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -6,229 775,574 -0.80 0.67 -4,173 519,635
2022-01-12 2022-01-06 4 ARDX ARDELYX, INC.
Stock Option (Right to Buy)
A - Award 700,000 700,000
2022-01-12 2022-01-06 4 ARDX ARDELYX, INC.
Common Stock
A - Award 150,000 781,803 23.74
2021-11-24 2021-11-22 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -2,607 631,803 -0.41 0.99 -2,586 626,685
2021-10-29 2021-10-08 4 ARDX ARDELYX, INC.
Common Stock
A - Award 300,000 634,410 89.71
2021-09-23 2021-09-21 4 TPST Tempest Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 6,635 6,635
2021-08-24 2021-08-20 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -2,573 329,730 -0.77 1.32 -3,396 435,244
2021-08-05 2021-08-03 4 ARDX ARDELYX, INC.
Stock Option (Right to Buy)
M - Exercise -267,892 0 -100.00
2021-08-05 2021-08-03 4 ARDX ARDELYX, INC.
Common Stock
F - Taxes -150,343 332,303 -31.15 1.64 -246,563 544,977
2021-08-05 2021-08-03 4 ARDX ARDELYX, INC.
Common Stock
M - Exercise 267,892 482,646 124.74 0.54 144,662 260,629
2021-06-29 2021-06-25 4 TPST Millendo Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 4,830 4,830
2021-06-29 2021-06-25 4 TPST Millendo Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 9,660 9,660
2021-06-29 2021-06-25 4 TPST Millendo Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 16,784 16,784
2021-06-14 2021-06-10 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 36,111 36,111
2021-06-14 2021-06-10 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 10,115 36,749 37.98
2021-05-21 2021-05-20 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -2,534 214,754 -1.17 7.09 -17,960 1,522,133
2021-05-20 2021-05-18 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
M - Exercise -5,634 0 -100.00
2021-05-20 2021-05-18 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 5,634 26,634 26.83 7.56 42,593 201,353
2021-02-24 2021-02-22 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -2,534 217,288 -1.15 6.88 -17,440 1,495,485
2021-01-07 2021-01-05 4 ARDX ARDELYX, INC.
Stock Option (Right to Buy)
A - Award 517,959 517,959
2021-01-07 2021-01-05 4 ARDX ARDELYX, INC.
Common Stock
A - Award 115,102 219,822 109.91
2020-09-17 2020-09-15 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -106,337 104,720 -50.38 5.61 -596,285 587,217
2020-07-06 2020-07-02 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -23,128 24,364 -48.70 7.01 -162,130 170,794
2020-06-12 2020-06-10 4 ARDX ARDELYX, INC.
Common Stock
J - Other 1,235 47,492 2.67
2020-06-08 2020-06-04 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 18,574 18,574
2020-06-08 2020-06-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 5,855 21,000 38.66
2020-06-03 2020-06-01 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
M - Exercise -5,000 0 -100.00
2020-06-03 2020-06-01 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -5,000 15,145 -24.82 12.65 -63,260 191,616
2020-06-03 2020-06-01 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 5,000 20,145 33.01 2.81 14,050 56,607
2020-06-02 2020-06-01 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -23,128 46,257 -33.33 7.33 -169,635 339,277
2020-05-05 2020-05-05 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -4,486 69,385 -6.07 7.03 -31,536 487,770
2020-05-05 2020-05-04 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -15,941 73,871 -17.75 7.01 -111,686 517,555
2020-04-17 2020-04-17 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -9,428 89,812 -9.50 7.02 -66,169 630,328
2020-04-17 2020-04-16 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -10,500 99,240 -9.57 7.01 -73,642 696,020
2020-04-17 2020-04-15 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -500 109,740 -0.45 7.03 -3,515 771,472
2020-03-04 2020-03-02 4 ARDX ARDELYX, INC.
Stock Option (Right to Buy)
M - Exercise -11,123 0 -100.00
2020-03-04 2020-03-02 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -20,428 110,240 -15.63 7.01 -143,284 773,234
2020-03-04 2020-03-02 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -11,123 208,057 -5.07 7.00 -77,861 1,456,399
2020-03-04 2020-03-02 4 ARDX ARDELYX, INC.
Common Stock
M - Exercise X 11,123 219,180 5.35 1.08 12,013 236,714
2020-02-07 2020-02-05 4 ARDX ARDELYX, INC.
Stock Option (Right to Buy)
M - Exercise -25,000 11,123 -69.21
2020-02-07 2020-02-05 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -25,000 206,828 -10.78 7.32 -182,928 1,513,381
2020-02-07 2020-02-05 4 ARDX ARDELYX, INC.
Common Stock
M - Exercise X 25,000 231,828 12.09 1.08 27,000 250,374
2020-01-13 2020-01-09 4 ARDX ARDELYX, INC.
Stock Option
A - Award 557,460 557,460
2019-07-01 2019-06-27 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 19,473 19,473
2019-07-01 2019-06-27 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 6,250 15,145 70.26
2019-06-06 2019-06-04 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -10,054 254,355 -3.80 2.54 -25,551 646,418
2019-06-04 2019-06-03 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
M - Exercise -5,000 0 -100.00
2019-06-04 2019-06-03 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -5,000 8,895 -35.98 11.16 -55,776 99,226
2019-06-04 2019-06-03 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 5,000 13,895 56.21 7.15 35,750 99,349
2019-01-22 2019-01-17 4 ARDX ARDELYX, INC.
Stock Option
A - Award 455,000 455,000
2019-01-04 2019-01-02 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -19,644 261,409 -6.99 1.70 -33,418 444,709
2018-11-15 2018-11-13 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -6,539 292,499 -2.19 2.84 -18,571 830,697
2018-07-30 2018-07-26 4 ARDX ARDELYX, INC.
Stock Option (Right to Buy)
A - Award 185,000 185,000
2018-07-30 2018-07-26 4 ARDX ARDELYX, INC.
Common Stock
A - Award 200,000 299,038 201.94
2018-06-11 2018-06-07 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 8,912 8,912
2018-06-11 2018-06-07 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 3,081 8,895 52.99
2018-04-18 2018-04-16 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
M - Exercise -5,000 0 -100.00
2018-04-18 2018-04-16 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
S - Sale X -5,000 5,814 -46.24 14.41 -72,058 83,788
2018-04-18 2018-04-16 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
M - Exercise 5,000 10,814 86.00 10.53 52,650 113,871
2018-01-18 2018-01-16 4 ARDX ARDELYX, INC.
Stock Option (Right to Buy)
A - Award 390,348 390,348
2018-01-04 2018-01-02 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
M - Exercise X -4,366 5,634 -43.66
2018-01-04 2018-01-02 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
M - Exercise X -5,000 5,000 -50.00
2018-01-04 2018-01-02 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
S - Sale X -9,366 5,814 -61.70 15.00 -140,490 87,210
2018-01-04 2018-01-02 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
M - Exercise X 9,366 15,180 161.09 15.00 140,490 227,700
2017-10-16 2017-10-12 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
M - Exercise X -5,000 5,000 -50.00
2017-10-16 2017-10-12 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
M - Exercise X -5,000 5,000 -50.00
2017-10-16 2017-10-12 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
S - Sale X -10,000 5,814 -63.24 14.25 -142,534 82,869
2017-10-16 2017-10-12 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
M - Exercise X 10,000 15,814 172.00 14.25 142,534 225,403
2017-08-11 2017-08-09 4 ARDX ARDELYX, INC.
Stock Option (Right to Buy)
A - Award 79,535 79,535
2017-08-11 2017-08-07 4 ARDX ARDELYX, INC.
Common Stock
A - Award 79,535 99,038 407.81
2017-06-15 2017-06-13 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 16,236 16,236
2017-06-15 2017-06-13 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 5,814 5,814
2017-01-23 2017-01-19 4 ARDX ARDELYX, INC.
Stock Option (Right to Buy)
A - Award 318,141 318,141
2017-01-23 2017-01-19 4 ARDX ARDELYX, INC.
Common Stock
A - Award 17,985 19,503 1,184.78
2016-06-13 2016-06-09 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 20,000 20,000
2016-01-20 2016-01-15 4 ARDX ARDELYX, INC.
Stock Option (Right to Buy)
A - Award 301,258 301,258
2015-09-10 2015-09-08 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -9,785 70,385 -12.21 20.29 -198,544 1,428,161
2015-08-27 2015-08-18 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -1,104 80,170 -1.36 20.00 -22,080 1,603,400
2015-08-04 2015-08-03 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -300 81,247 -0.37 20.00 -6,000 1,624,940
2015-07-30 2015-07-28 4 ARDX ARDELYX, INC.
Common Stock
S - Sale X -2,111 81,547 -2.52 20.00 -42,220 1,630,940
2015-06-12 2015-06-10 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 20,000 20,000
2015-06-09 2015-06-08 4 FOLD AMICUS THERAPEUTICS INC
Common stock
D - Sale to Issuer X -8,936 0 -100.00 12.65 -113,040
2015-03-12 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock
J - Other 27 27
2015-01-08 2015-01-06 4 ARDX ARDELYX, INC.
Stock Option (Right to Buy)
A - Award 75,000 75,000
2014-06-18 3 ARDX ARDELYX, INC.
Common Stock
167,316
2014-06-18 3 ARDX ARDELYX, INC.
Common Stock
167,316
2014-06-16 2014-06-12 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 15,000 15,000
2013-06-17 2013-06-13 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 15,000 15,000
2012-06-15 2012-06-13 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 15,000 15,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)